Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. scores highest on Nitro (45) and lowest on Price (0). Its PosiPenta is 29.18 out of 100, weaker than most similar companies.
On the Penta Grid this week, Pelthos Therapeutics Inc. is Grid #769 of 837 in the Healthcare sector in United States, and Grid #3,657 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Pelthos Therapeutics Inc. | 29.18 | 0 | 37 | 45 | 20 | 44 |
| CareCloud, Inc. | 50.82 | 35 | 87 | 38 | 49 | 45 |
| Acrivon Therapeutics, Inc. | 42.54 | 42 | 32 | 43 | 54 | 42 |
| Telomir Pharmaceuticals, Inc. | 39.98 | 4 | 58 | 55 | 40 | 43 |
| Citius Oncology, Inc. | 41.57 | 29 | 62 | 41 | 31 | 45 |
| LENSAR, Inc. | 48.65 | 34 | 40 | 39 | 76 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.73 |
| P/B ratio | -51.39 |
EEarnings
| Trailing EPS | ₹-2607.50 |
| Forward EPS | ₹-486.52 |
NNitro
| Price | 1908.51 |
| 52-week high | 3551.81 |
| 52-week low | 1722.87 |
| Fall from 52-week high | 46.3% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.90 |
AAnchor
| Beta (price swings) | 3.11 |
| Market cap | ₹730 Cr |
| Insider holding | 50.05% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Pelthos Therapeutics Inc.'s PosiPenta score?
Pelthos Therapeutics Inc.'s PosiPenta is 29.18 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Pelthos Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, Pelthos Therapeutics Inc. is Grid #769 of 837 in the Healthcare sector in United States, and Grid #3,657 of 4,000 in United States.
Which PosiPenta pillar is strongest for Pelthos Therapeutics Inc.?
Nitro (momentum), with a score of 45 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Pelthos Therapeutics Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Pelthos Therapeutics Inc.'s PosiPenta changed since last week?
Yes, it rose 2.97 points, from 26.21 to 29.18.
PositoAI is for research and education only and is not investment advice.